Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK1358820 in post-stroke upper limb spasticity
NCT00460564Phase 3Completed
- Sponsor
- GSK
- Start
- May 2007
- Primary completion
- Dec 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of onabotulinumtoxinA in Spasticity, sponsored by GSK. Started May 2007; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
Spasticity
Beyond the preview
Go deeper on NCT00460564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00460564.